Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Focal adhesion | R-HSA-354113 | map04510 | bupropion | 444 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | bupropion | 444 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | bupropion | 444 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | bupropion | 444 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | bupropion | 444 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | bupropion | 444 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | bupropion | 444 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | bupropion | 444 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | bupropion | 444 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | novobiocin | 2467 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | novobiocin | 2467 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | novobiocin | 2467 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | novobiocin | 2467 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | novobiocin | 2467 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | novobiocin | 2467 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | novobiocin | 2467 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | novobiocin | 2467 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | novobiocin | 2467 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | novobiocin | 2467 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | novobiocin | 2467 | drug-path |